Targovax's Viral IO Therapy, Anticancer Vaccine Aimed At Combos
Executive Summary
Targovax’s strategy is to use its products as immune response primers and combine them with other anticancer therapies, but the Norwegian biotech will need a partner for eventual late stage trials, its management tells Scrip.